护佑品牌怎么样 申请店铺

我要投票 护佑在医疗用品行业中的票数:191 更新时间:2025-04-20
护佑是哪个国家的品牌?「护佑」是 扬子江药业集团有限公司 旗下著名品牌。该品牌发源于江苏省泰州市,由创始人徐镜人在2001-03-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力护佑品牌出海!通过在本页面挂载护佑品牌的产品链接和联系邮箱,可以提高护佑产品曝光!跨境电商爆单神器,目前只要100元/年哦~

护佑怎么样

创建于1971年,拥有中西药并举,处方药与非处方药并重的产品体系,产学研/科工贸一体化的创新型医药企业集团


扬子江药业集团创建于1971年,是一家跨地区、产学研相结合、科工贸一体化的国家大型医药企业集团。集团总部位于江苏省泰州市,现有员工15000人,总占地面积300多万平方米。旗下15家成员公司分布泰州、北京、上海、南京、广州、成都、苏州、常州等地;营销网络覆盖除台湾以外的全国各省、市、自治区。

扬子江药业集团把研发创新作为企业发展战略基点,致力于国家一类新药和创新药物的研发。集团坚持不懈走创新之路,在新药研发上,全面推进“三药并举”战略,以每年按销售额3~4%比例投入新药研发,抢占科技制高点,引进具有国际视野的高端研发创新人才,建立国际化研发体系。目前在研的化学创新药、仿制药、中药和生物药达100多个,确保了短期、中期和长期产品研发有序进行。经过多年的积累和创新,产品体系覆盖10多个领域、10多种剂型、200多个品规。集团一直以市场为导向,研发产品以抗感染、心脑血管、消化系统为主,并积极开拓其它具有增长潜力的用药市场,形成“研发一批、生产一批、储备一批”的产品梯队,有力保证了企业的持续健康发展。

集团根据中医泰斗董建华院士等名老中医的验方,相继成功研发并上市胃苏颗粒、荜铃胃痛颗粒、蓝芩口服液、双花百合片、香芍颗粒、百乐眠胶囊、黄芪精口服液、柴芩清宁胶囊、青乳消颗粒、补肾润肺口服液、神曲消食口服液等一大批疗效独特的中药精品,为无数患者送去健康福音。正在建设的龙凤堂中药项目,将致力于药材自动化前处理——智能投料——原辅料、成品无人输送——机器人码垛——自动控温立体高架库储存等技术攻尖,全力打造现代化中药智能工厂。

集团发展不忘回报社会,多年来在赈灾、扶贫、拥军、助学以及各种人道主义救助活动中始终走在全社会的前列。集团至今连续16多年资助“中华医学科技奖”评选,鼎力支持祖国医学科技进步。汶川大地震发、天津港爆炸、盐城龙卷风灾害发生后,扬子江在第一时间捐赠款物,奉献爱心。

面向未来,奋进中的扬子江药业集团以振兴民族医药为己任,怀着科学、严谨、负责的态度,竭诚为全人类的健康服务。


Founded in 1971, Yangzijiang Pharmaceutical Group, an innovative pharmaceutical enterprise group with the integration of production, research, science, industry and trade, is a large-scale national pharmaceutical enterprise group with the integration of science, industry and trade and the combination of production, research and research. Headquartered in Taizhou City, Jiangsu Province, the group has 15000 employees and covers an area of more than 3 million square meters. Its 15 member companies are distributed in Taizhou, Beijing, Shanghai, Nanjing, Guangzhou, Chengdu, Suzhou, Changzhou and other places; the marketing network covers all provinces, cities and autonomous regions except Taiwan. Yangzijiang Pharmaceutical Group takes R & D and innovation as the strategic basis of enterprise development, and is committed to the R & D of national first-class new drugs and innovative drugs. The Group continues to take the road of innovation. In terms of new drug research and development, the group comprehensively promotes the strategy of "three drugs simultaneously". It invests in new drug research and development at the proportion of 3-4% of sales every year, seizes the commanding point of science and technology, introduces high-end R & D and innovation talents with international vision, and establishes an international R & D system. At present, more than 100 chemical innovative drugs, generic drugs, traditional Chinese medicine and biological drugs are under research, ensuring the orderly development of short-term, medium-term and long-term products. After years of accumulation and innovation, the product system covers more than 10 fields, more than 10 dosage forms and more than 200 product specifications. The group has always been market-oriented. Its R & D products mainly focus on anti infection, cardio cerebrovascular and digestive system, and actively explore other drug markets with growth potential, forming a product echelon of "R & D, production and storage", which effectively ensures the sustainable and healthy development of the enterprise. The group has successfully developed and listed a large number of excellent TCM products with unique curative effects, such as Weisu granule, bieling Weitong granule, Lanqin oral liquid, Shuanghua Lily tablet, Xiangshao granule, bailemining capsule, Huangqi essence oral liquid, chaiqinqingning capsule, qingruxiao granule, Bushen Runfei oral liquid, Shenqu Xiaoshi oral liquid, according to the prescription of famous old TCM, such as academician Dong Jianhua, the leader of traditional Chinese medicine Countless patients sent health gospel. The longfengtang traditional Chinese medicine project under construction will focus on the technology of automatic pre-processing of traditional Chinese Medicine - Intelligent feeding - raw and auxiliary materials, unmanned transportation of finished products - robot stacking - automatic temperature control three-dimensional elevated warehouse storage, and strive to build a modern intelligent factory of traditional Chinese medicine. The development of the group does not forget to repay the society, and it has always been in the forefront of the whole society in disaster relief, poverty alleviation, supporting the army, education and various humanitarian relief activities for many years. The group has supported the selection of "Chinese medical science and Technology Award" for more than 16 years in a row, making great efforts to support the progress of medical science and technology in China. After the Wenchuan earthquake, Tianjin Port explosion and Yancheng tornado disaster, the Yangtze River donated money and goods for the first time. Facing the future, the striving Yangtze River Pharmaceutical Group takes the rejuvenation of national medicine as its own duty, with a scientific, rigorous and responsible attitude, and wholeheartedly serves the health of all mankind.

本文链接: https://brand.waitui.com/4682ce224.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

沃尔沃将在美国裁员多至800人,以应对关税影响

沃尔沃集团发言人当地时间4月18日表示,受美国关税政策影响,沃尔沃集团计划在未来三个月内在美国三家工厂裁员多至800人。沃尔沃集团北美公司在一份声明中说,该公司已告知员工,计划在宾夕法尼亚州、马里兰州以及弗吉尼亚州的工厂裁员550人至800人。(界面新闻)

2小时前

敦煌网:97个国家GMV增速超100%

随着敦煌网在全球热度的持续攀升,近日平台97个国家交易额增速超过100%,其中交易额贡献TOP5国家为美国、英国、加拿大、法国、澳大利亚。单日新注册买家数量自4月15日开始连续多日同比上周增长近20倍。平台多品类GMV增长明显,其中户外装备的新买家交易量增长195%,宠物用品增长近130%,发制品激增671%,家电增长962%,安防跃升601%,健康与美容品类增长318%。(界面新闻)

2小时前

五一假期出行预订进入高潮:酒店搜索热度翻倍,“请4休11”拼假带动长线旅游

随着五一火车票的开售,五一假期出行预订进入高潮。近日,多家在线旅游平台发布的数据显示,旅游市场的消费活力将在五一假期持续释放。携程数据显示,近一周境内酒店搜索热度环比暴涨100%,机票搜索热度飙升80%。其中,在“请4休11”拼假策略带动下,跨市住宿订单占比已突破80%,县域市场高星酒店消费反超高线城市,入境游订单同比激增173%,全民开启“假日经济新玩法”。(澎湃新闻)

2小时前

关税政策叠加负面因素冲击美旅游业,3月赴美游客锐减12%

3月赴美外国游客数量同比下降近12%,这是自新冠疫情以来的最大降幅。《华盛顿邮报》援引美国商务部下属的国际贸易署的数据称,3月份中美洲的赴美游客同比减少24%,来自西欧国家的游客同比减少17%,其中德国游客数量的下降28%、西班牙下降25%。以上数据并不包含美国国际游客最大来源国加拿大。根据加拿大政府的初步统计数据显示,截至3月,驾车访问美国的加拿大公民人数同比下降了近32%。从美国乘飞机返回加拿大的人数下降了13.5%。美国旅游协会预测,2025年美国旅游业收入或将减少720亿美元,酒店、航空、餐饮等行业将面临连锁反应。此外,美国高盛集团预测称,在最坏情况下,入境游客和消费双双减少可能给今年美国GDP造成0.3%的损失,约合9000亿美元。(央视新闻)

2小时前

北京文化声明:近日关于《封神2》的网络相关信息不实

据“北京文化BC”微信公众号,近日,公司发现有部分网友于互联网上发布关于公司出品电影《封神第二部:战火西岐》的不实言论,对此北京文化严正声明,关于该电影的相关信息均依北京文化发布的公告为准,其余均为不实信息。互联网并非法外之地,请大家不信谣不传谣,北京文化亦保留采取法律手段追究相关责任方法律责任的权利。

2小时前

本页详细列出关于丽珠医药LIVZON的品牌信息,含品牌所属公司介绍,丽珠医药LIVZON所处行业的品牌地位及优势。
咨询